236 related articles for article (PubMed ID: 17449411)
1. Management of pulmonary arterial hypertension with a focus on combination therapies.
Benza RL; Park MH; Keogh A; Girgis RE
J Heart Lung Transplant; 2007 May; 26(5):437-46. PubMed ID: 17449411
[TBL] [Abstract][Full Text] [Related]
2. Endothelin antagonism in pulmonary arterial hypertension.
Lee SH; Channick RN
Semin Respir Crit Care Med; 2005 Aug; 26(4):402-8. PubMed ID: 16121317
[TBL] [Abstract][Full Text] [Related]
3. An evidence-based approach to the management of pulmonary arterial hypertension.
Archer SL; Michelakis ED
Curr Opin Cardiol; 2006 Jul; 21(4):385-92. PubMed ID: 16755209
[TBL] [Abstract][Full Text] [Related]
4. Synergistic therapeutic effects of 2-methoxyestradiol with either sildenafil or bosentan on amelioration of monocrotaline-induced pulmonary hypertension and vascular remodeling.
Tofovic SP; Jones TJ; Bilan VP; Jackson EK; Petrusevska G
J Cardiovasc Pharmacol; 2010 Nov; 56(5):475-83. PubMed ID: 20881615
[TBL] [Abstract][Full Text] [Related]
5. Long-term follow-up after conversion from intravenous epoprostenol to oral therapy with bosentan or sildenafil in 13 patients with pulmonary arterial hypertension.
Johnson RF; Loyd JE; Mullican AL; Fink CA; Robbins IM
J Heart Lung Transplant; 2007 Apr; 26(4):363-9. PubMed ID: 17403478
[TBL] [Abstract][Full Text] [Related]
6. Endothelin receptor expression in idiopathic pulmonary arterial hypertension: effect of bosentan and epoprostenol treatment.
Hall SM; Davie N; Klein N; Haworth SG
Eur Respir J; 2011 Oct; 38(4):851-60. PubMed ID: 21406517
[TBL] [Abstract][Full Text] [Related]
7. Pharmacologic treatment for pulmonary arterial hypertension.
Sastry BK
Curr Opin Cardiol; 2006 Nov; 21(6):561-8. PubMed ID: 17053404
[TBL] [Abstract][Full Text] [Related]
8. Long-term effects of inhaled treprostinil in patients with pulmonary arterial hypertension: the Treprostinil Sodium Inhalation Used in the Management of Pulmonary Arterial Hypertension (TRIUMPH) study open-label extension.
Benza RL; Seeger W; McLaughlin VV; Channick RN; Voswinckel R; Tapson VF; Robbins IM; Olschewski H; Rubin LJ
J Heart Lung Transplant; 2011 Dec; 30(12):1327-33. PubMed ID: 22055098
[TBL] [Abstract][Full Text] [Related]
9. HIV-related pulmonary arterial hypertension: clinical presentation and management.
Sitbon O
AIDS; 2008 Sep; 22 Suppl 3():S55-62. PubMed ID: 18845923
[TBL] [Abstract][Full Text] [Related]
10. Bosentan and sildenafil: should the combination therapy be a valid alternative in childhood to prostacyclin infusion?
Brancaccio G; Toscano A; Bevilacqua M; Di Chiara L; Parisi F
Pediatr Transplant; 2007 Feb; 11(1):110-2. PubMed ID: 17239133
[TBL] [Abstract][Full Text] [Related]
11. Long-term outcome of systemic sclerosis-associated pulmonary arterial hypertension treated with bosentan as first-line monotherapy followed or not by the addition of prostanoids or sildenafil.
Launay D; Sitbon O; Le Pavec J; Savale L; Tchérakian C; Yaïci A; Achouh L; Parent F; Jais X; Simonneau G; Humbert M
Rheumatology (Oxford); 2010 Mar; 49(3):490-500. PubMed ID: 20015974
[TBL] [Abstract][Full Text] [Related]
12. Combination therapy and new types of agents for pulmonary arterial hypertension.
O'Callaghan DS; Gaine SP
Clin Chest Med; 2007 Mar; 28(1):169-85, ix. PubMed ID: 17338934
[TBL] [Abstract][Full Text] [Related]
13. Addition of sildenafil to bosentan monotherapy in pulmonary arterial hypertension.
Mathai SC; Girgis RE; Fisher MR; Champion HC; Housten-Harris T; Zaiman A; Hassoun PM
Eur Respir J; 2007 Mar; 29(3):469-75. PubMed ID: 17079256
[TBL] [Abstract][Full Text] [Related]
14. How has epoprostenol changed the outcome for patients with pulmonary arterial hypertension?
Barst R
Int J Clin Pract Suppl; 2010 Nov; (168):23-32. PubMed ID: 20939843
[TBL] [Abstract][Full Text] [Related]
15. Changing the prognosis of pulmonary arterial hypertension: impact of medical therapy.
Chakinala MM
Semin Respir Crit Care Med; 2005 Aug; 26(4):409-16. PubMed ID: 16121318
[TBL] [Abstract][Full Text] [Related]
16. Successful epoprostenol withdrawal in pulmonary arterial hypertension: case report and literature review.
Demerouti EA; Manginas AN; Athanassopoulos GD; Karatasakis GT; Leontiadis ED; Pavlides GS
Respir Care; 2013 Feb; 58(2):e1-5. PubMed ID: 22710078
[TBL] [Abstract][Full Text] [Related]
17. Advances in diagnosis and treatment in patients with pulmonary arterial hypertension.
Park MH
Catheter Cardiovasc Interv; 2008 Feb; 71(2):205-13. PubMed ID: 18327839
[TBL] [Abstract][Full Text] [Related]
18. The management of pregnancy and pregnancy-related medical conditions in pulmonary arterial hypertension patients.
Hsu CH; Gomberg-Maitland M; Glassner C; Chen JH
Int J Clin Pract Suppl; 2011 Aug; (172):6-14. PubMed ID: 21736676
[TBL] [Abstract][Full Text] [Related]
19. Pulmonary arterial hypertension associated with interferon beta treatment for multiple sclerosis: a case report.
Ledinek AH; Jazbec SS; Drinovec I; Rot U
Mult Scler; 2009 Jul; 15(7):885-6. PubMed ID: 19465452
[TBL] [Abstract][Full Text] [Related]
20. Pulmonary arterial hypertension: the most devastating vascular complication of systemic sclerosis.
McLaughlin V; Humbert M; Coghlan G; Nash P; Steen V
Rheumatology (Oxford); 2009 Jun; 48 Suppl 3():iii25-31. PubMed ID: 19487219
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
